TABLE 1.
Derivation dataset (n = 159) |
Validation dataset (n = 160) |
|||
Characteristic | MCI converters (n = 41) | MCI nonconverters (n = 118) | MCI converters (n = 33) | MCI nonconverters (n = 127) |
Age (y) | 72 ± 7 | 73 ± 8 | 73 ± 8 | 73 ± 8 |
Sex (n) | ||||
Male | 14 | 55 | 18 | 49 |
Female | 27 | 63 | 16 | 111 |
Mean FAQ ± SD | 2.4 ± 3.8 | 2.7 ± 3.7 | 2.3 ± 3.5 | 2.4 ± 3.8 |
Mean MMSE ± SD | 27.8 ± 1.8 | 27.7 ± 1.8 | 28.1 ± 1.6 | 28.1 ± 1.5 |
APOE ε4–positive rate | 78% | 49% | 90% | 40% |
Amyloid-positive rate | 87% | 48% | 94% | 52% |
Mean time to conversion (mo) | 41 | — | 37 | — |
Follow-up time (mo) | ||||
Median | 48 | 47 | ||
95% confidence interval | 36–51 | 35–52 |